Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308954671> ?p ?o ?g. }
- W4308954671 endingPage "730" @default.
- W4308954671 startingPage "722" @default.
- W4308954671 abstract "Fenestrated/branched endovascular aortic repair (F/BEVAR) in patients with occluded iliac arteries is challenging owing to limited access for branch vessel catheterization and increased risk for leg and spinal ischemic complications. The aim of this study was to analyze technical strategies and outcomes of F/BEVAR in patients with unilateral iliofemoral occlusive disease.We performed a retrospective review of all consecutive patients treated by F/BEVAR in two institutions (2003-2021). Patients with unilateral iliofemoral occlusive disease were included in the analysis. All patients had one patent iliac artery that was used for advancement of the fenestrated-branch component. Preloaded catheter/guidewire systems or steerable sheaths were used as adjuncts to facilitate catheterization. Primary endpoints were technical success, mortality, major adverse events (stroke, spinal cord injury, dialysis or decrease in the glomerular filtration rate of more than 50%, bowel ischemia, myocardial infarction, or respiratory failure), primary iliac patency, and freedom from reinterventions.There were 959 patients treated with F/BEVAR. Of these, 15 patients (1.56%; mean age, 74 years; 80% male) had occluded iliac arteries and 1 patent iliofemoral access and were treated for a thoracoabdominal aortic aneurysm (n = 8) or juxtarenal abdominal aortic aneurysm (n = 7). Brachial access was used in 14 of the 15 patients and preloaded systems in 7 of the 15 patients (47%). The remaining 53% had staggered deployment of stent grafts. There were seven physician-modified endovascular grafts, seven custom-made devices, and one off-the-shelf device used. Thirteen patients (87%) had distal seal using aortouni-iliac stent grafts and two (13%) had distal seal in the infrarenal aorta. Concomitant femoral crossover bypass (FCB) was performed in two patients and six patients had a prior FCB. Technical success was 100%. There were no intraoperative complications or early lower extremity ischemic complications, and all FCB were preserved. There was one mortality (7%) within 30 days owing to retrograde type A dissection. Major adverse events occurred in 20% of patients. The median follow-up was 12 months (range, 0-85 months). Two patients (13%) required three reinterventions. One patient required proximal stent graft extension for an acute type B dissection (3 months) and another required iliac extension for type Ib endoleak of an aortouni-iliac graft (21 months) and thrombolysis of that extension (50 months). At last follow-up, all patients had primary graft patency except one with secondary graft patency without new claudication. One patient had a single renal artery stent occlusion at follow-up with no r-intervention. The overall survival rate was 60%, without aortic-related deaths.Although challenging, F/BEVAR with unilateral femoral/brachial approach is feasible in patients with occluded iliac limbs, with an important rate of ischemic complications, but satisfactory outcomes." @default.
- W4308954671 created "2022-11-20" @default.
- W4308954671 creator A5023443145 @default.
- W4308954671 creator A5028429089 @default.
- W4308954671 creator A5039253984 @default.
- W4308954671 creator A5039761037 @default.
- W4308954671 creator A5042852452 @default.
- W4308954671 creator A5043875322 @default.
- W4308954671 creator A5050309812 @default.
- W4308954671 creator A5065997886 @default.
- W4308954671 date "2023-03-01" @default.
- W4308954671 modified "2023-10-01" @default.
- W4308954671 title "Fenestrated/branched endovascular aortic repair using unilateral femoral access in patients with iliac occlusive disease" @default.
- W4308954671 cites W2045427391 @default.
- W4308954671 cites W2073510727 @default.
- W4308954671 cites W2092650611 @default.
- W4308954671 cites W2108105224 @default.
- W4308954671 cites W2131065877 @default.
- W4308954671 cites W2143300420 @default.
- W4308954671 cites W2152614958 @default.
- W4308954671 cites W2158086472 @default.
- W4308954671 cites W2165573618 @default.
- W4308954671 cites W2325008173 @default.
- W4308954671 cites W2408270188 @default.
- W4308954671 cites W2535509083 @default.
- W4308954671 cites W2789982436 @default.
- W4308954671 cites W2898709349 @default.
- W4308954671 cites W2941322719 @default.
- W4308954671 cites W2970388575 @default.
- W4308954671 cites W2970392944 @default.
- W4308954671 cites W2986232463 @default.
- W4308954671 cites W2996276164 @default.
- W4308954671 cites W3015027508 @default.
- W4308954671 cites W3016469782 @default.
- W4308954671 cites W3036106151 @default.
- W4308954671 cites W3037104672 @default.
- W4308954671 cites W3081539021 @default.
- W4308954671 cites W3082610752 @default.
- W4308954671 cites W3107152341 @default.
- W4308954671 cites W3108925016 @default.
- W4308954671 cites W3118727223 @default.
- W4308954671 cites W3127201020 @default.
- W4308954671 cites W3171980780 @default.
- W4308954671 doi "https://doi.org/10.1016/j.jvs.2022.10.049" @default.
- W4308954671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36372375" @default.
- W4308954671 hasPublicationYear "2023" @default.
- W4308954671 type Work @default.
- W4308954671 citedByCount "1" @default.
- W4308954671 countsByYear W43089546712023 @default.
- W4308954671 crossrefType "journal-article" @default.
- W4308954671 hasAuthorship W4308954671A5023443145 @default.
- W4308954671 hasAuthorship W4308954671A5028429089 @default.
- W4308954671 hasAuthorship W4308954671A5039253984 @default.
- W4308954671 hasAuthorship W4308954671A5039761037 @default.
- W4308954671 hasAuthorship W4308954671A5042852452 @default.
- W4308954671 hasAuthorship W4308954671A5043875322 @default.
- W4308954671 hasAuthorship W4308954671A5050309812 @default.
- W4308954671 hasAuthorship W4308954671A5065997886 @default.
- W4308954671 hasBestOaLocation W43089546711 @default.
- W4308954671 hasConcept C118552586 @default.
- W4308954671 hasConcept C126322002 @default.
- W4308954671 hasConcept C126838900 @default.
- W4308954671 hasConcept C141071460 @default.
- W4308954671 hasConcept C2776098176 @default.
- W4308954671 hasConcept C2776543907 @default.
- W4308954671 hasConcept C2777597760 @default.
- W4308954671 hasConcept C2778583881 @default.
- W4308954671 hasConcept C2778620186 @default.
- W4308954671 hasConcept C2778692183 @default.
- W4308954671 hasConcept C2778750487 @default.
- W4308954671 hasConcept C2779959501 @default.
- W4308954671 hasConcept C2779980429 @default.
- W4308954671 hasConcept C2779993416 @default.
- W4308954671 hasConcept C2780775167 @default.
- W4308954671 hasConcept C2994150672 @default.
- W4308954671 hasConcept C535046627 @default.
- W4308954671 hasConcept C71924100 @default.
- W4308954671 hasConceptScore W4308954671C118552586 @default.
- W4308954671 hasConceptScore W4308954671C126322002 @default.
- W4308954671 hasConceptScore W4308954671C126838900 @default.
- W4308954671 hasConceptScore W4308954671C141071460 @default.
- W4308954671 hasConceptScore W4308954671C2776098176 @default.
- W4308954671 hasConceptScore W4308954671C2776543907 @default.
- W4308954671 hasConceptScore W4308954671C2777597760 @default.
- W4308954671 hasConceptScore W4308954671C2778583881 @default.
- W4308954671 hasConceptScore W4308954671C2778620186 @default.
- W4308954671 hasConceptScore W4308954671C2778692183 @default.
- W4308954671 hasConceptScore W4308954671C2778750487 @default.
- W4308954671 hasConceptScore W4308954671C2779959501 @default.
- W4308954671 hasConceptScore W4308954671C2779980429 @default.
- W4308954671 hasConceptScore W4308954671C2779993416 @default.
- W4308954671 hasConceptScore W4308954671C2780775167 @default.
- W4308954671 hasConceptScore W4308954671C2994150672 @default.
- W4308954671 hasConceptScore W4308954671C535046627 @default.
- W4308954671 hasConceptScore W4308954671C71924100 @default.
- W4308954671 hasFunder F4320332457 @default.
- W4308954671 hasIssue "3" @default.
- W4308954671 hasLocation W43089546711 @default.